A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer
CLINICAL BREAST CANCER (2008)
Journal
CLINICAL BREAST CANCER
Volume 8, Issue 3, Pages 264-268Publisher
CIG MEDIA GROUP, LP
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies
Sarah J. Nagle, Catherine Murphree, Philipp W. Raess, Levanto Schachter, Andy Chen, Brandon Hayes-Lattin, Eneida Nemecek, Richard T. Maziarz
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Cumulative menstrual months and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities Study
Sarah E. Cole, Esther M. John, Lisa M. Hines, Amanda Phipps, Jocelyn Koo, Sue A. Ingles, Kathy B. Baumgartner, Martha L. Slattery, Roberta McKean-Cowden, Anna H. Wu
INTERNATIONAL JOURNAL OF CANCER (2022)
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes
Elle N. Clelland, Harriet T. Rothschild, Anne Patterson, Julissa Molina-Vega, Mandeep Kaur, W. Fraser Symmans, Christopher J. Schwartz, A. Jo Chien, Christopher C. Benz, Rita A. Mukhtar
BREAST CANCER RESEARCH AND TREATMENT (2023)
Pre- and post-weaning nutrition status affects sheep mammary gland morphology and promotes differential gene expression
H. Mirzaei-Alamouti, R. Hadionnejad, A. Abdollahi, A. Bahari, F. Fatahnia, R. Masoumi, M. P. Green, M. Vazirigohar, M. Mansouryar
ANIMAL BIOTECHNOLOGY (2023)
Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective
Xiaohui Si, Tianning Gu, Lianxuan Liu, Yue Huang, Yingli Han, Pengxu Qian, He Huang
CANCER LETTERS (2022)
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy
Lulu Cui, Jia Huang, Yongtao Zhan, Ni Qiu, Huan Jin, Jia Li, Huiqi Huang, Hongsheng Li
LIFE SCIENCES (2021)
Hematologic complications of immune checkpoint inhibitors
Michael H. Kroll, Cristhiam Rojas-Hernandez, Cassian Yee
BLOOD (2022)
Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
Wenjing Luo, Chenggong Li, Yinqiang Zhang, Mengyi Du, Haiming Kou, Cong Lu, Heng Mei, Yu Hu
BMC CANCER (2022)
Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+)
Xinli Wang, Yan Xue
FRONTIERS IN ENDOCRINOLOGY (2023)
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, Donatella Gambini, Concetta Blundo, Letterio Runza, Stefano Ferrero, Elena Guerini-Rocco, Nicola Fusco
BMC CANCER (2021)
Molecular mechanisms of anthracycline cardiovascular toxicity
Anna Narezkina, K. Hari Narayan, Alice E. Zemljic-Harpf
CLINICAL SCIENCE (2021)
Allred Scoring of ER-IHC Stained Whole-Slide Images for Hormone Receptor Status in Breast Carcinoma
Mohammad Faizal Ahmad Fauzi, Wan Siti Halimatul Munirah Wan Ahmad, Mohammad Fareed Jamaluddin, Jenny Tung Hiong Lee, See Yee Khor, Lai Meng Looi, Fazly Salleh Abas, Nouar Aldahoul
DIAGNOSTICS (2022)
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Carmelita Abrahams, Nicholas J. Woudberg, Sandrine Lecour
LIPIDS IN HEALTH AND DISEASE (2022)
The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies
Zilong Guo, Yirui Zhang, Mingpeng Fu, Liang Zhao, Zhen Wang, Zhuoshuo Xu, Huifen Zhu, Xiaoli Lan, Guanxin Shen, Yong He, Ping Lei
FRONTIERS IN IMMUNOLOGY (2021)
Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer
Jiuyan Shang, Xuemei Sun, Zihang Xu, Lijing Cai, Chang Liu, Si Wu, Yueping Liu
FRONTIERS IN ONCOLOGY (2023)
Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience
E. M. Trivino-Ibanez, P. Pardo Moreno, J. J. Ciampi Dopazo, C. Ramos-Fonta, G. Ruiz Villaverde, E. Gonzalez-Flores, P. F. Navarro Vergara, M. Rashki, M. Gomez-Rio, A. Rodriguez-Fernandez
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR (2022)
Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer
Tania Calvo-Lopez, Mateo Paz-Cabezas, Patricia Llovet, Maria Dolores Ibanez, Javier Sastre, Vicente Alonso-Orduna, J. Ma Vieitez, Alfonso Yubero, Ruth Vera, Elena Asensio-Martinez, Pilar Garcia-Alfonso, Enrique Aranda, Eduardo Diaz-Rubio, Beatriz Perez-Villamil
CANCER BIOMARKERS (2022)
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Manuel Benavides, Auxiliadora Gomez-Espana, Pilar Garcia-Alfonso, Cristina Garcia Gonzalez, Jose Maria Vieitez, Fernando Rivera, Maria Jose Safont, Albert Abad, Javier Sastre, Manuel Valladares-Ayerbes, Alfredo Carrato, Encarnacion Gonzalez-Flores, Luis Robles, Antonieta Salud, Vicente Alonso-Orduna, Clara Montagut, Elena Asensio, Eduardo Diaz-Rubio, Enrique Aranda
EJSO (2022)
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor- positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER)
J. Albanell, M. T. Martinez, M. Ramos, M. O'Connor, L. de la Cruz-Merino, A. Santaballa, N. Martinez-Janez, F. Moreno, I Fernandez, J. Alarcon, J. A. Virizuela, J. de la Haba-Rodriguez, P. Sanchez-Rovira, L. Gonzalez-Cortijo, M. Margeli, A. Sanchez-Munoz, A. Anton, M. Casas, S. Bezares, F. Rojo
EUROPEAN JOURNAL OF CANCER (2022)
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial
Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, Tadeusz Pienkowski, Young-Hyuck Im, Giulia Valeria Bianchi, Barbara Galbardi, Matteo Dugo, Loris De Cecco, Ling-Ming Tseng, Mei-Ching Liu, Begona Bermejo, Vladimir Semiglazov, Giulia Viale, Juan de la Haba-Rodriguez, Do-Youn Oh, Brigitte Poirier, Pinuccia Valagussa, Luca Gianni, Elda Tagliabue
MOLECULAR ONCOLOGY (2022)
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Miguel Martin, Christoph Zielinski, Manuel Ruiz-Borrego, Eva Carrasco, Eva M. Ciruelos, Montserrat Munoz, Begona Bermejo, Mireia Margeli, Tibor Csoszi, Antonio Anton, Nicholas Turner, Maria Casas, Serafin Morales, Emilio Alba, Lourdes Calvo, Juan De La Haba-Rodriguez, Manuel Ramos, Laura Murillo, Ana Santaballa, Jose L. Alonso-Romero, Pedro Sanchez-Rovira, Massimo Corsaro, Xin Huang, Christiane Thallinger, Zsuzsanna Kahan, Miguel Gil-Gil
EUROPEAN JOURNAL OF CANCER (2022)
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab
M. Jose Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna, M. Teresa Cano, Auxiliadora Gomez-Espana, Juan R. De la Haba-Rodriguez, Antonio Rodriguez-Ariza, Enrique Aranda
CANCERS (2022)
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study
Alfonso Yubero, Aranzazu Barquin, Purificacion Estevez, Bella Pajares, Luisa Sanchez, Piedad Reche, Jesus Alarcon, Julia Calzas, Lydia Gaba, Jose Fuentes, Ana Santaballa, Carmen Salvador, Luis Manso, Ana Herrero, Alvaro Taus, Raul Marquez, Julia Madani, Maria Merino, Gloria Marquina, Victoria Casado, Manuel Constenla, Maria Gutierrez, Alba Dosil, Antonio Gonzalez-Martin
BMC CANCER (2022)
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2-advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Javier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, Elena Galve Calvo, Cristina Hernando Melia, Eva Maria Ciruelos Gil, Maria Vidal, Begona Jimenez-Rodriguez, Luis De la Cruz Merino, Noelia Martinez Janez, Rafael Villanueva Vazquez, Ruben de Toro Salas, Antonio Anton Torres, Isabel Manuela Alvarez Lopez, Joaquin Gavila Gregori, Vanesa Quiroga Garcia, Elena Vicente Rubio, Juan de la Haba-Rodriguez, Santiago Gonzalez-Santiago, Nieves Diaz Fernandez, Agusti Barnadas Molins, Blanca Cantos Sanchez de Ibarguen, Juan Ignacio Delgado Mingorance, Meritxell Bellet Ezquerra, Sonia de Casa, Asuncion Gimeno, Miguel Martin
BREAST (2022)
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis
Grazia Arpino, Juan de la Haba Rodriguez, Jean -Marc Ferrero, Sabino De Placido, Dirk Klingbiel, Valentine Revelant, Christine Wohlfarth, Raf Poppe, Mothaffar F. Rimawi
CLINICAL CANCER RESEARCH (2023)
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, Gorka Alkorta-Aranburu, Jose Ramon Antunez-Lopez, Gema Moreno-Bueno, Jose Palacios, Alfonso Yubero, Raul Marquez, Alejandro Gallego, Ana Beatriz Sanchez-Heras, Jose Antonio Lopez-Guerrero, Cristina Perez-Segura, Pilar Barretina-Ginesta, Jesus Alarcon, Lydia Gaba, Antonia Marquez, Judit Matito, Juan Cueva, Isabel Palacio, Maria Iglesias, Angels Arcusa, Luisa Sanchez-Lorenzo, Eva Guerra-Alia, Ignacio Romero, Ana Vivancos
JOURNAL OF PERSONALIZED MEDICINE (2022)
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
Nicholas C. Turner, Mafalda Oliveira, Sacha J. Howell, Florence Dalenc, Javier Cortes, Henry L. Gomez Moreno, Xichun Hu, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Meena Okera, Yeon Hee Park, Joohyuk Sohn, Masakazu Toi, Eriko Tokunaga, Samih Yousef, Lyudmila Zhukova, Elza C. de Bruin, Lynda Grinsted, Gaia Schiavon, Andrew Foxley, Hope S. Rugo
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis
Ana Isabel Tristan, Encarnacion Gonzalez-Flores, Ana del Mar Salmeron, Ana Cristina Abreu, Octavio Caba, Cristina Jimenez-Luna, Consolacion Melguizo, Jose Prados, Ignacio Fernandez
NMR IN BIOMEDICINE (2023)
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy
Silvia Guil-Luna, Aurora Rivas-Crespo, Carmen Navarrete-Sirvent, Ana Mantrana, Alejandra Pera, Rafael Mena-Osuna, Marta Toledano-Fonseca, Maria Victoria Garcia-Ortiza, Carlos Villar, Maria Teresa Sanchez-Montero, Janna Krueger, Francisco Javier Medina-Fernandez, Juan De La Haba-Rodriguez, Auxiliadora Gomez-Espana, Enrique Aranda, Christopher E. Rudd, Antonio Rodriguez-Ariza
BIOMEDICINE & PHARMACOTHERAPY (2023)
SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021)
Juan de la Haba-rodriguez, Ferran Ferragut Lloret, Maria Angeles Vaz Salgado, Martin Ore Arce, Ana Cardena Gutierrez, Jesus Garcia-Donas Jimenez, Carmen Beato Zambrano, Rosa Maria Rodriguez Alonso, Rafael Lopez Lopez, Nuria Rodriguez Salas
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)